Current campaigns

Have your say on PBS listings for IBD medications – March 2022

The Pharmaceutical Benefits Advisory Committee (PBAC) is seeking consumer feedback on an ulcerative colitis medication.

If you have experience taking Ozanimod you may like to provide feedback on what difference it has made to your life by email to [email protected].

CCA will then forward your comments grouped with those of others to PBAC.

The closing date for comments to CCA is 20 January 2022.


Submission type
(new listing, change to listing)

Drug Name, form(s), strength(s) and Sponsor
(Drug name, form, strength, Trade name®, Sponsor)
Drug Type and Use
(What is the drug used to treat?)
Listing requested by Sponsor / Purpose of Submission
(Includes type of listing requested (unrestricted, restricted benefit, authority required) and restriction wording.  If restriction is lengthy it may be paraphrased.)

Change to PBS listing

OZANIMOD

Capsule 920 micrograms
Pack containing 4 capsules 230 micrograms and 3 capsules 460 micrograms

Zeposia®

Celgene Pty Limited

Ulcerative Colitis

To request a General Schedule Authority Required (Written) listing for the
treatment of moderate to severe ulcerative colitis.

 

Have your say on PBS listings for IBD medications – September 2020

Submissions closed

Have your say to support the PBS listings of Adalimumab biosimilar – Hadlima®.

Submissions closed

Have your say to support the PBS listings of Adalimumab biosimilar – Hyrimoz®, Mesalazine suppositories and granules – Pentasa®, protein formula – Modulen IBD® or Tofacitinib – Xeljanz®.

Submissions closed

Have your say to support the PBS listing of Stelara for treatment of Crohn’s disease in adults

Submissions closed

Have  your say and let the PBS know your needs for treatment of ulcerative colitis

Submissions closed

Have  your say and support the PBS listing of Humira for treatment of Ulcerative Colitis

Submissions closed

Have your say about getting Vedolizumab on the PBS listing for treatment of Crohn’s disease and ulcerative colitis! 

Submissions closed

Have your say and support the PBS listing of Humira for treatment of paediatric Crohn’s!

Submissions closed